Palantir Just Proved the Bears Wrong Again — Which Is Exactly Why the Bears Aren't Going Anywhere

# Palantir Just Proved the Bears Wrong Again — Which Is Exactly Why the Bears Aren't Going Anywhere

Here's the trade that's been humiliating short sellers for three years running: bet against Palantir's valuation, get run over by Palantir's growth. Rinse, repeat, cry into your risk model. Q2 2026 was just the latest installment.

Going into earnings on August 3, PLTR was a stock everyone loved to hate. Down almost 5% in the trailing month, sitting near the bottom of its 52-week range at $123.06, with Jefferies' Brent Thill waving a Street-low $70 price target like a fire alarm and RBC reportedly grumbling about valuation right before the print. Short interest north of 77 million shares. A trailing P/E of 138. The setup was practically begging for a valuation reckoning.

Instead, Palantir did what Palantir does: it beat, it raised, and the stock ripped +15% in a single session. Karp's crew delivered what one analyst had called a "solid beat and raise" — and then actually delivered it, with commercial AI demand, record contract growth, and higher full-year guidance all showing up in the same release. Eight consecutive quarters of EPS beats is now nine. At some point "surprising" analysts stops being a surprise and starts being a pattern they should probably just build into their models.

The bull case is not subtle, and it's not wrong. 85% year-over-year revenue growth in Q1, a "blowout" Q2, the U.S. Army tapping Palantir Foundry as the data layer for its flagship NGC2 modernization program, Maven AI locking down Pentagon "program-of-record" status (that's the kind of designation that quietly guarantees multi-year funding while everyone's busy arguing about the P/E ratio), and a fresh partnership with Nvidia that reframes Palantir as the orchestration layer sitting on top of the AI infrastructure everyone else is racing to build. This is a company simultaneously winning government trust and commercial adoption at the same time — a combination almost nobody else in software can claim credibly.

But let's not pretend the valuation math has gotten any less absurd. At roughly 80x sales, Palantir isn't priced like a great software company — it's priced like the entire category has already been won, permanently, with no competitive response coming from Amazon, Microsoft, or Google. That's a heroic assumption. One quantitative model actually pegs the bull case target at just $81 — below where the stock traded even before the earnings pop. When your bear case and your bull case can't agree within a factor of five ($70 vs. $382 in year-end projections floating around), what you're really looking at is a stock priced almost entirely on narrative momentum, with fundamentals serving as supporting cast rather than lead actor.

That's not a knock on the business. It's a warning about the stock. Revenue growth at 85% with 46% operating margins and $1.75 billion in free cash flow is genuinely elite — this isn't a story stock burning capital on vibes. But a 138x trailing P/E means the market has already underwritten years of flawless execution. Government contracts are lumpy by nature. Commercial AIP retention hasn't been stress-tested through a real slowdown. And SBC dilution keeps quietly nibbling at per-share value while everyone's staring at the top-line growth chart.

So where does that leave you? If you already own it, the thesis just got reconfirmed — guidance raises and Pentagon program-of-record status don't happen to companies losing their grip on their core markets. Let it ride, but know what you're holding: a momentum stock with excellent fundamentals wrapped around a valuation that has zero tolerance for a stumble.

If you don't own it and you're tempted to chase the post-earnings pop, ask yourself honestly whether you're buying the business or buying the candle. Because at 80x sales, the next disappointing quarter — not a bad one, just a less spectacular one — is the kind of thing that turns a 15% up day into a 25% down day. Palantir has earned the benefit of the doubt. It has not earned immunity from gravity.